<DOC>
	<DOCNO>NCT00461695</DOCNO>
	<brief_summary>Recent study indicate persistent viral infection particularly Cytomegalovirus ( CMV ) might negative impact immune senescence ( i.e . immunocompetence elderly individual ) . We test hypothesis perform vaccination trial healthy elderly individual subdivide two group CMV-seropositive CMV-seronegative individual . All individual vaccinate currently license vaccine prevention TBE ( FSME Immun CC ) recommend general population area . Vaccination efficacy monitor longitudinally concern TBEV-specific antibody ( TBEV-neutralization , TBEV-specific ELISA ) T cell response ( ELISpot , cytokine production ) . Vaccination efficacy compare CMV+ CMV- individual correlate CMV-specific immune response CMV+ individual .</brief_summary>
	<brief_title>Influence Persistent CMV-infection Immune Senescence</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Encephalitis , Tick-Borne</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : Age &gt; 70 year Healthy accord health questionnaire ( complete screening ) TBEVaccination indicate ( exposure TBEVinfested tick possible ) Capable make inform decision understand inform consent form Informed consent sign patient study physician Exclusion criterion : Previous exposure TBEV ( natural vaccination ) Immunodeficiency , history autoimmune disease current intake immunemodulating drug ( corticosteroid a.s.o . ) Persistent ( &gt; 3 month ) pharmacological treatment one drug relevance ( exception : combination antihypertensive ) Contraindication TBEVvaccination Condition would drastically interfere clinic attendance and/or adherence protocol Past medical history current treatment one follow condition : Chronic cardiac disease ( Coronary heart disease , heart failure ) , chronic pulmonary disease ( COPD ) , chronic kidney disease , diabetes mellitus , previous stroke , epilepsy , Parkinsons disease , dementia Hemoglobin &lt; 12 g/l Random plasma glucose ( RPG ) &gt; 11.1 mmol/l OR fast plasma glucose ( FPG ) &gt; 6.9 mmol/l ( FPG require , RPG 7.011.0 mmol/l ) Calculated CreatininClearance &lt; 50 ml/min TBEVserology positive</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Cytomegalovirus ( CMV )</keyword>
	<keyword>Tick-borne encephalitis virus ( TBEV )</keyword>
	<keyword>Ageing</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Immunity</keyword>
</DOC>